MAPT and insomnia measurement: For example, insomnia is associated with impaired clearance of amyloid β-protein and tau protein by the lymphatic system, systemic inflammation, and neuroendocrine dysregulation, all of which are implicated in the pathogenesis of AD but may precede observable changes in cognitive performance by years or even decades [44,46,49].